BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32159797)

  • 1. Potent Inhibitors of Organic Anion Transporters 1 and 3 From Natural Compounds and Their Protective Effect on Aristolochic Acid Nephropathy.
    Li C; Wang X; Bi Y; Yu H; Wei J; Zhang Y; Han L; Zhang Y
    Toxicol Sci; 2020 Jun; 175(2):279-291. PubMed ID: 32159797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I.
    Xue X; Gong LK; Maeda K; Luan Y; Qi XM; Sugiyama Y; Ren J
    Mol Pharm; 2011 Dec; 8(6):2183-92. PubMed ID: 21980933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of rhein and Rheum palmatum L. extract on the pharmacokinetics and tissue distribution of aristolochic acid I and its demethylated metabolite in rats.
    Ma L; Shen Z; Hu H; Zhou H; Yu L; Jiang H; Zeng S
    J Ethnopharmacol; 2021 Mar; 267():113537. PubMed ID: 33137430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From the Cover: Identification of Natural Products as Inhibitors of Human Organic Anion Transporters (OAT1 and OAT3) and Their Protective Effect on Mercury-Induced Toxicity.
    Wang X; Han L; Li G; Peng W; Gao X; Klaassen CD; Fan G; Zhang Y
    Toxicol Sci; 2018 Feb; 161(2):321-334. PubMed ID: 29045746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for an involvement of organic anion transporters (OATs) in aristolochic acid nephropathy.
    Bakhiya N; Arlt VM; Bahn A; Burckhardt G; Phillips DH; Glatt H
    Toxicology; 2009 Oct; 264(1-2):74-9. PubMed ID: 19643159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3.
    Zou L; Matsson P; Stecula A; Ngo HX; Zur AA; Giacomini KM
    J Pharm Sci; 2021 Jan; 110(1):347-353. PubMed ID: 32910949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential interactions of the β-lactam cloxacillin with human renal organic anion transporters (OATs).
    Lalanne S; Le Vée M; Lemaitre F; Le Corre P; Verdier MC; Fardel O
    Fundam Clin Pharmacol; 2020 Aug; 34(4):476-483. PubMed ID: 32100322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting renal OATs to develop renal protective agent from traditional Chinese medicines: Protective effect of Apigenin against Imipenem-induced nephrotoxicity.
    Huo X; Meng Q; Wang C; Wu J; Zhu Y; Sun P; Ma X; Sun H; Liu K
    Phytother Res; 2020 Nov; 34(11):2998-3010. PubMed ID: 32468621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
    Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
    Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
    El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
    Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment and characterization of Mardin-Darby canine kidney cells stably expressing human organic anion transporters.
    Shin HJ; Lee CH; Park SJ; Shin JG; Song IS
    Arch Pharm Res; 2010 May; 33(5):709-16. PubMed ID: 20512469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Organic anion transporter 1 (OAT1) involved in renal cell transport of aristolochic acid I.
    Zeng Y; Zhang R; Wu J; Liu M; Peng W; Yu X; Yang X
    Hum Exp Toxicol; 2012 Aug; 31(8):759-70. PubMed ID: 22027505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organic anion transporter 3- and organic anion transporting polypeptides 1B1- and 1B3-mediated transport of catalposide.
    Jeong HU; Kwon M; Lee Y; Yoo JS; Shin DH; Song IS; Lee HS
    Drug Des Devel Ther; 2015; 9():643-53. PubMed ID: 25653502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity.
    Hagos Y; Wolff NA
    Toxins (Basel); 2010 Aug; 2(8):2055-82. PubMed ID: 22069672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions.
    Lu H; Lu Z; Li X; Li G; Qiao Y; Borris RP; Zhang Y
    PeerJ; 2017; 5():e3333. PubMed ID: 28560096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acamprosate Is a Substrate of the Human Organic Anion Transporter (OAT) 1 without OAT3 Inhibitory Properties: Implications for Renal Acamprosate Secretion and Drug-Drug Interactions.
    Antonescu IE; Karlgren M; Pedersen ML; Simoff I; Bergström CAS; Neuhoff S; Artursson P; Steffansen B; Nielsen CU
    Pharmaceutics; 2020 Apr; 12(4):. PubMed ID: 32344570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dihydrophenanthrenes from Juncus effusus as Inhibitors of OAT1 and OAT3.
    Li X; Qiao Y; Wang X; Ma R; Li T; Zhang Y; Borris RP
    J Nat Prod; 2019 Apr; 82(4):832-839. PubMed ID: 30892891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated single-cell transcriptomics and proteomics reveal cellular-specific responses and microenvironment remodeling in aristolochic acid nephropathy.
    Chen J; Luo P; Wang C; Yang C; Bai Y; He X; Zhang Q; Zhang J; Yang J; Wang S; Wang J
    JCI Insight; 2022 Aug; 7(16):. PubMed ID: 35852860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of human organic anion transporters with various cephalosporin antibiotics.
    Takeda M; Babu E; Narikawa S; Endou H
    Eur J Pharmacol; 2002 Mar; 438(3):137-42. PubMed ID: 11909604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.